首页 > 最新文献

Experimental Biology and Medicine最新文献

英文 中文
Bioinformatics-based screening and validation of ferroptosis-related genes in sepsis and type 2 diabetes mellitus. 败血症和2型糖尿病中铁中毒相关基因的生物信息学筛选和验证。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-21 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10612
Heng Xiao, Zhonghua Ding, Cheng Liu, Xu He, Yanyan Tao

Emerging clinical evidence underscores a bidirectional epidemiological linkage between sepsis and type 2 diabetes mellitus (T2DM). This study mechanistically investigates the underlying pathogenesis of this comorbidity, specifically focusing on the role of ferroptosis-related genes in its pathogenesis. A total of 1204 shared genes between sepsis and T2DM were screened using datasets from sepsis (GSE65682) and T2DM (GSE76894). GO and KEGG enrichment analyses, combined with WGCNA, were performed to identify key pathways and hub genes. Three signaling pathways-MAPK, adherens junction, and peroxisome-were significantly associated with the sepsis-T2DM interaction. Subsequent Pearson correlation analysis implicated ferroptosis as a critically involved process. Five core ferroptosis-related genes, including CDC25B, DPP7, FBXO31, PTCD3, and CNPY2, were were identified and experimentally validated using qRT-PCR. Furthermore, based on cMAP, we screened eight candidate drugs targeting these genes. Echinacea and Ibudilast were predicted to possess the greatest preclinical potential among them. This study provides a deeper insight into the shared pathogenesis of sepsis and T2DM, highlighting the pivotal role of ferroptosis in the development and progression of this comorbidity. Our findings offer preliminary insights into the sepsis-T2DM comorbidity, highlighting ferroptosis as a potential key pathological mechanism and identifying candidate targets for future therapeutic exploration.

新出现的临床证据强调了败血症和2型糖尿病(T2DM)之间的双向流行病学联系。本研究从机制上探讨了这种合并症的潜在发病机制,特别关注了嗜铁病相关基因在其发病机制中的作用。使用脓毒症(GSE65682)和T2DM (GSE76894)的数据集筛选脓毒症和T2DM之间共有1204个共享基因。GO和KEGG富集分析结合WGCNA进行鉴定关键通路和枢纽基因。三种信号通路- mapk,粘附体连接和过氧化物酶体-与败血症- t2dm相互作用显著相关。随后的Pearson相关分析暗示铁下垂是一个关键的参与过程。利用qRT-PCR技术鉴定并验证了5个核心枯铁相关基因CDC25B、DPP7、FBXO31、PTCD3和CNPY2。此外,基于cMAP,我们筛选了8种靶向这些基因的候选药物。其中,紫锥菊和布司特的临床前应用潜力最大。这项研究为脓毒症和T2DM的共同发病机制提供了更深入的见解,强调了铁下垂在这种合并症的发生和进展中的关键作用。我们的研究结果为败血症- t2dm合并症提供了初步的见解,强调了铁下垂是一种潜在的关键病理机制,并确定了未来治疗探索的候选靶点。
{"title":"Bioinformatics-based screening and validation of ferroptosis-related genes in sepsis and type 2 diabetes mellitus.","authors":"Heng Xiao, Zhonghua Ding, Cheng Liu, Xu He, Yanyan Tao","doi":"10.3389/ebm.2025.10612","DOIUrl":"10.3389/ebm.2025.10612","url":null,"abstract":"<p><p>Emerging clinical evidence underscores a bidirectional epidemiological linkage between sepsis and type 2 diabetes mellitus (T2DM). This study mechanistically investigates the underlying pathogenesis of this comorbidity, specifically focusing on the role of ferroptosis-related genes in its pathogenesis. A total of 1204 shared genes between sepsis and T2DM were screened using datasets from sepsis (GSE65682) and T2DM (GSE76894). GO and KEGG enrichment analyses, combined with WGCNA, were performed to identify key pathways and hub genes. Three signaling pathways-MAPK, adherens junction, and peroxisome-were significantly associated with the sepsis-T2DM interaction. Subsequent Pearson correlation analysis implicated ferroptosis as a critically involved process. Five core ferroptosis-related genes, including CDC25B, DPP7, FBXO31, PTCD3, and CNPY2, were were identified and experimentally validated using qRT-PCR. Furthermore, based on cMAP, we screened eight candidate drugs targeting these genes. Echinacea and Ibudilast were predicted to possess the greatest preclinical potential among them. This study provides a deeper insight into the shared pathogenesis of sepsis and T2DM, highlighting the pivotal role of ferroptosis in the development and progression of this comorbidity. Our findings offer preliminary insights into the sepsis-T2DM comorbidity, highlighting ferroptosis as a potential key pathological mechanism and identifying candidate targets for future therapeutic exploration.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10612"},"PeriodicalIF":2.7,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12583109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TIMAP downregulation in Burkitt's lymphoma reveals key molecules and signaling pathways in B-cell lymphomagenesis. TIMAP在伯基特淋巴瘤中的下调揭示了b细胞淋巴瘤发生的关键分子和信号通路。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10533
Marya Obeidat, Saleh Tadros, Batool Ismail, Ayah Al-Khaldi

Burkitt's lymphoma (BL) is an aggressive subtype of B-cell non-Hodgkin's lymphoma, known for its rapid tumor growth and poor prognosis. Transforming growth factor beta-inhibited membrane-associated protein (TIMAP) is a regulatory subunit of protein phosphatase 1 catalytic subunit, enriched in lymphoid tissues, and upregulated in various cancers. Despite suggestions that TIMAP promotes lymphomagenesis in a c-myc-driven model, its precise role remains unclear. This study aimed to investigate the contribution of TIMAP to B-cell lymphomagenesis by examining transcriptomic changes upon TIMAP downregulation in BL cells. Raji BL cells were transfected with 2'Fluoro Arabinonucleic acid (FANA)-antisense oligonucleotides (ASO) targeting TIMAP (FANA-ASO-TIMAP) or a scramble control (FANA-ASO-Scramble). TIMAP expression was significantly reduced at the mRNA (0.70 ± 0.04, p = 0.001) and protein levels (median = 0.73, IQR = 0.13, p = 0.002). RNA sequencing identified 2,368 differentially expressed genes (DEGs), of which 1,326 were upregulated, and 1,042 were downregulated. Gene Ontology analysis revealed that the DEGs were primarily involved in cellular processes, DNA replication, intracellular signal transduction, and apoptosis. Pathways related to lymphoma progression, such as B-cell receptor signaling, p53 signaling, and mTOR signaling, were notably affected. Key genes such as PAK3, LINC00487, AID, PURPL, and BCL2 were among the most dysregulated, highlighting TIMAP's role in critical oncogenic pathways in B-cell Lymphoma. These findings suggest that TIMAP is a key regulator of gene expression and signaling pathways in B-cell lymphomagenesis and could serve as a potential therapeutic target for novel treatments.

伯基特淋巴瘤(BL)是b细胞非霍奇金淋巴瘤的一种侵袭性亚型,以肿瘤生长迅速和预后差而闻名。转化生长因子β抑制膜相关蛋白(TIMAP)是蛋白磷酸酶1催化亚基的调控亚基,在淋巴组织中富集,在多种癌症中上调。尽管TIMAP在c-myc驱动的模型中促进了淋巴瘤的发生,但其确切作用尚不清楚。本研究旨在通过检测TIMAP在BL细胞中下调后的转录组变化,探讨TIMAP在b细胞淋巴瘤发生中的作用。用2'氟阿拉伯核酸(FANA)-靶向TIMAP的反义寡核苷酸(ASO) (FANA-ASO-TIMAP)或乱序对照(FANA-ASO- scramble)转染Raji BL细胞。TIMAP mRNA(0.70±0.04,p = 0.001)和蛋白水平(中位数= 0.73,IQR = 0.13, p = 0.002)均显著降低。RNA测序鉴定出2368个差异表达基因(deg),其中1326个表达上调,1042个表达下调。基因本体分析显示,deg主要参与细胞过程、DNA复制、细胞内信号转导和细胞凋亡。与淋巴瘤进展相关的通路,如b细胞受体信号、p53信号和mTOR信号,受到明显影响。PAK3、LINC00487、AID、PURPL和BCL2等关键基因均出现了最严重的失调,这表明TIMAP在b细胞淋巴瘤的关键致癌途径中发挥了作用。这些发现表明TIMAP是b细胞淋巴瘤发生过程中基因表达和信号通路的关键调节因子,可以作为新疗法的潜在治疗靶点。
{"title":"TIMAP downregulation in Burkitt's lymphoma reveals key molecules and signaling pathways in B-cell lymphomagenesis.","authors":"Marya Obeidat, Saleh Tadros, Batool Ismail, Ayah Al-Khaldi","doi":"10.3389/ebm.2025.10533","DOIUrl":"10.3389/ebm.2025.10533","url":null,"abstract":"<p><p>Burkitt's lymphoma (BL) is an aggressive subtype of B-cell non-Hodgkin's lymphoma, known for its rapid tumor growth and poor prognosis. Transforming growth factor beta-inhibited membrane-associated protein (TIMAP) is a regulatory subunit of protein phosphatase 1 catalytic subunit, enriched in lymphoid tissues, and upregulated in various cancers. Despite suggestions that TIMAP promotes lymphomagenesis in a <i>c-myc</i>-driven model, its precise role remains unclear. This study aimed to investigate the contribution of TIMAP to B-cell lymphomagenesis by examining transcriptomic changes upon TIMAP downregulation in BL cells. Raji BL cells were transfected with 2'Fluoro Arabinonucleic acid (FANA)-antisense oligonucleotides (ASO) targeting TIMAP (FANA-ASO-TIMAP) or a scramble control (FANA-ASO-Scramble). TIMAP expression was significantly reduced at the mRNA (0.70 ± 0.04, p = 0.001) and protein levels (median = 0.73, IQR = 0.13, p = 0.002). RNA sequencing identified 2,368 differentially expressed genes (DEGs), of which 1,326 were upregulated, and 1,042 were downregulated. Gene Ontology analysis revealed that the DEGs were primarily involved in cellular processes, DNA replication, intracellular signal transduction, and apoptosis. Pathways related to lymphoma progression, such as B-cell receptor signaling, p53 signaling, and mTOR signaling, were notably affected. Key genes such as <i>PAK3</i>, <i>LINC00487</i>, <i>AID</i>, <i>PURPL,</i> and <i>BCL2</i> were among the most dysregulated, highlighting TIMAP's role in critical oncogenic pathways in B-cell Lymphoma. These findings suggest that TIMAP is a key regulator of gene expression and signaling pathways in B-cell lymphomagenesis and could serve as a potential therapeutic target for novel treatments.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10533"},"PeriodicalIF":2.7,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12568449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glaucoma and cardiovascular disease: a bidirectional two-sample Mendelian randomization analysis. 青光眼和心血管疾病:双向双样本孟德尔随机化分析。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10610
Dongdong Jin, Jie Sun, Wei Zhang, Mingxuan Zhang, Chengfang Li

Many studies reported that glaucoma is associated with cardiovascular disease (CVD). This study aims to investigate the potential causal relationship between glaucoma and CVD using a bidirectional two-sample Mendelian randomization (MR) analysis. The genome-wide association studies (GWAS) of glaucoma and CVD were downloaded from the IEU OpenGWAS project. The CVD included unstable angina pectoris (UAP), coronary artery disease (CAD), high blood pressure (HBP), myocardial infarct (MI), heart failure (HF), ischemic stroke (IS), atrial fibrillation (AF), and pulmonary embolism (PE). The inverse variance weighting (IVW) analysis was the primary method in MR analysis. Meanwhile, sensitivity analysis and statistical power tests were performed. The random effects IVW method showed a causal relationship between glaucoma and a decreased risk of MI (Odds ratio (OR): 0.94, 95% confidence interval (CI): 0.89-0.99; P = 0.012). In the reverse MR analysis, genetic susceptibility of UAP (OR: 1.12, 95% CI: 1.02-1.23; P = 0.022), CAD (OR: 1.1, 95% CI: 1-1.21; P = 0.041), and HBP (OR: 1.83, 95% CI: 1.25-2.67; P = 0.002) was significantly linked to an increased risk of glaucoma. MR-Egger (P = 0.005) and IVW (P = 0.005) methods found that HBP presented different degrees of heterogeneity. The random effects IVW method also demonstrated that HBP is the risk factor for glaucoma (P = 0.0017). Although reverse MR initially suggested a potential association between CAD and glaucoma, MVMR showed no causal relationship after adjusting for obesity and BMI. The MR analysis found that glaucoma serves as a protective factor for MI, while UAP and HBP were risk factors for glaucoma in the European population, which may contribute to preventing and managing glaucoma and CVD.

许多研究报道青光眼与心血管疾病(CVD)有关。本研究旨在通过双向双样本孟德尔随机化(MR)分析来探讨青光眼和心血管疾病之间的潜在因果关系。青光眼和心血管疾病的全基因组关联研究(GWAS)从IEU OpenGWAS项目下载。CVD包括不稳定型心绞痛(UAP)、冠状动脉疾病(CAD)、高血压(HBP)、心肌梗死(MI)、心力衰竭(HF)、缺血性中风(IS)、心房颤动(AF)和肺栓塞(PE)。反方差加权(IVW)分析是MR分析的主要方法。同时进行敏感性分析和统计功效检验。随机效应IVW方法显示青光眼与心肌梗死风险降低之间存在因果关系(优势比(OR): 0.94, 95%可信区间(CI): 0.89-0.99;P = 0.012)。在反向MR分析中,UAP (OR: 1.12, 95% CI: 1.02-1.23; P = 0.022)、CAD (OR: 1.1, 95% CI: 1-1.21; P = 0.041)和HBP (OR: 1.83, 95% CI: 1.25-2.67; P = 0.002)的遗传易感性与青光眼风险增加显著相关。MR-Egger (P = 0.005)和IVW (P = 0.005)方法发现HBP存在不同程度的异质性。随机效应IVW法也显示血压是青光眼的危险因素(P = 0.0017)。虽然反向MR最初提示CAD和青光眼之间存在潜在关联,但在调整肥胖和BMI后,MVMR显示没有因果关系。MR分析发现青光眼是心肌梗死的保护因素,而UAP和HBP是欧洲人群青光眼的危险因素,这可能有助于预防和控制青光眼和心血管疾病。
{"title":"Glaucoma and cardiovascular disease: a bidirectional two-sample Mendelian randomization analysis.","authors":"Dongdong Jin, Jie Sun, Wei Zhang, Mingxuan Zhang, Chengfang Li","doi":"10.3389/ebm.2025.10610","DOIUrl":"10.3389/ebm.2025.10610","url":null,"abstract":"<p><p>Many studies reported that glaucoma is associated with cardiovascular disease (CVD). This study aims to investigate the potential causal relationship between glaucoma and CVD using a bidirectional two-sample Mendelian randomization (MR) analysis. The genome-wide association studies (GWAS) of glaucoma and CVD were downloaded from the IEU OpenGWAS project. The CVD included unstable angina pectoris (UAP), coronary artery disease (CAD), high blood pressure (HBP), myocardial infarct (MI), heart failure (HF), ischemic stroke (IS), atrial fibrillation (AF), and pulmonary embolism (PE). The inverse variance weighting (IVW) analysis was the primary method in MR analysis. Meanwhile, sensitivity analysis and statistical power tests were performed. The random effects IVW method showed a causal relationship between glaucoma and a decreased risk of MI (Odds ratio (OR): 0.94, 95% confidence interval (CI): 0.89-0.99; P = 0.012). In the reverse MR analysis, genetic susceptibility of UAP (OR: 1.12, 95% CI: 1.02-1.23; P = 0.022), CAD (OR: 1.1, 95% CI: 1-1.21; P = 0.041), and HBP (OR: 1.83, 95% CI: 1.25-2.67; P = 0.002) was significantly linked to an increased risk of glaucoma. MR-Egger (P = 0.005) and IVW (P = 0.005) methods found that HBP presented different degrees of heterogeneity. The random effects IVW method also demonstrated that HBP is the risk factor for glaucoma (P = 0.0017). Although reverse MR initially suggested a potential association between CAD and glaucoma, MVMR showed no causal relationship after adjusting for obesity and BMI. The MR analysis found that glaucoma serves as a protective factor for MI, while UAP and HBP were risk factors for glaucoma in the European population, which may contribute to preventing and managing glaucoma and CVD.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10610"},"PeriodicalIF":2.7,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12568447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the microbiological mechanism of Tongxie Yaofang in treating IBS-D: a multimodal mechanistic study in mice integrating network pharmacology, computational simulation, and 16S rRNA sequencing. 通泻药方治疗IBS-D的微生物机制解读:结合网络药理学、计算模拟和16S rRNA测序的小鼠多模式机制研究
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-03 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10725
Donglin Yu, Qianghong Tian, Junxi Shen, Leyao Fang, Zhoujin Tan, Ying Cai

Irritable bowel syndrome with diarrhea (IBS-D), associated with the traditional Chinese medicine (TCM) pattern of liver hyperactivity with spleen deficiency pattern, lacks effective Western treatments. The modern biological relevance of the "intestine-liver-bile acid" axis aligns with this TCM concept, and interactions between intestinal microbiota and diarrhea remain unclear. Network pharmacology, molecular docking, and molecular dynamics were applied to elucidate the mechanisms and compound-target stability of Tongxie Yaofang. An IBS-D mouse model was established using Senna alexandrina Mill. combined with confinement stress. Histopathological changes in the liver and spleen were assessed by hematoxylin-eosin (HE) staining, and enzyme-linked immunosorbent assay (ELISA) was performed to quantify total bile acid levels in serum and liver. Ultimately, 16S rRNA high-throughput sequencing was employed to identify predominant and distinctive bacterial species. Network pharmacology and molecular docking revealed that Tongxie Yaofang acts primarily through the TNF-α and IL-17 pathways. Molecular dynamics confirmed strong binding affinities between active compounds (naringenin, divaricatol, and kaempferol) and target proteins. In vivo, Tongxie Yaofang alleviated colonic inflammation, increased serum bile acid levels, reduced hepatic bile acid concentrations, and increased intestinal microbial diversity and abundance. The therapeutic effects of Tongxie Yaofang on IBS-D are mechanistically linked to its multi-target actions, including suppression of inflammatory responses, inhibition of pathogenic bacterial overgrowth, restoration of immune homeostasis, and modulation of intestinal microbiota composition toward a probiotic-enriched community.

肠易激综合征伴腹泻(IBS-D)具有肝亢脾虚的中医证型,缺乏有效的西医治疗。“肠-肝-胆汁酸”轴的现代生物学相关性与这一中医概念一致,肠道微生物群与腹泻之间的相互作用仍不清楚。采用网络药理学、分子对接、分子动力学等方法对通泻要方的作用机制和化合物靶标稳定性进行了研究。采用山参草建立IBS-D小鼠模型。加上约束应力。采用苏木精-伊红(HE)染色观察肝、脾组织病理变化,采用酶联免疫吸附试验(ELISA)测定血清和肝脏总胆汁酸水平。最终,采用16S rRNA高通量测序鉴定优势和独特的细菌种类。网络药理学与分子对接发现痛泻要方主要通过TNF-α和IL-17通路起作用。分子动力学证实了活性化合物(柚皮素、多元醇和山奈酚)与靶蛋白之间的强结合亲和力。在体内,通泻要方可减轻结肠炎症,提高血清胆汁酸水平,降低肝脏胆汁酸浓度,增加肠道微生物多样性和丰度。通泻药方对IBS-D的治疗作用与其多靶点作用机制相关,包括抑制炎症反应、抑制病原菌过度生长、恢复免疫稳态、调节肠道菌群组成,形成益生菌富集群落。
{"title":"Deciphering the microbiological mechanism of Tongxie Yaofang in treating IBS-D: a multimodal mechanistic study in mice integrating network pharmacology, computational simulation, and 16S rRNA sequencing.","authors":"Donglin Yu, Qianghong Tian, Junxi Shen, Leyao Fang, Zhoujin Tan, Ying Cai","doi":"10.3389/ebm.2025.10725","DOIUrl":"10.3389/ebm.2025.10725","url":null,"abstract":"<p><p>Irritable bowel syndrome with diarrhea (IBS-D), associated with the traditional Chinese medicine (TCM) pattern of liver hyperactivity with spleen deficiency pattern, lacks effective Western treatments. The modern biological relevance of the \"intestine-liver-bile acid\" axis aligns with this TCM concept, and interactions between intestinal microbiota and diarrhea remain unclear. Network pharmacology, molecular docking, and molecular dynamics were applied to elucidate the mechanisms and compound-target stability of Tongxie Yaofang. An IBS-D mouse model was established using <i>Senna alexandrina</i> Mill. combined with confinement stress. Histopathological changes in the liver and spleen were assessed by hematoxylin-eosin (HE) staining, and enzyme-linked immunosorbent assay (ELISA) was performed to quantify total bile acid levels in serum and liver. Ultimately, 16S rRNA high-throughput sequencing was employed to identify predominant and distinctive bacterial species. Network pharmacology and molecular docking revealed that Tongxie Yaofang acts primarily through the TNF-α and IL-17 pathways. Molecular dynamics confirmed strong binding affinities between active compounds (naringenin, divaricatol, and kaempferol) and target proteins. <i>In vivo</i>, Tongxie Yaofang alleviated colonic inflammation, increased serum bile acid levels, reduced hepatic bile acid concentrations, and increased intestinal microbial diversity and abundance. The therapeutic effects of Tongxie Yaofang on IBS-D are mechanistically linked to its multi-target actions, including suppression of inflammatory responses, inhibition of pathogenic bacterial overgrowth, restoration of immune homeostasis, and modulation of intestinal microbiota composition toward a probiotic-enriched community.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10725"},"PeriodicalIF":2.7,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145328188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the dual role of CD3G: a diagnostic biomarker for depression and its oncogenic implications. 揭示CD3G的双重作用:抑郁症的诊断生物标志物及其致癌意义。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10599
Hai Gao, Ting Wu, Jihui Xue, Jing Liu, Dongmei Wen, Guanwei Huang

Depression has been increasingly associated with immune system dysregulation. This study investigates the potential of CD3 Gamma Subunit of T-Cell Receptor Complex (CD3G) as a diagnostic marker for depression, while also examining its role across various cancer types. Comparative analyses of immune cell infiltration and pathway activities were conducted using single-sample Gene Set Enrichment Analysis (ssGSEA) on datasets GSE98793. Depression patients were defined based on clinical diagnoses and compared to healthy controls (HC) without any psychiatric disorders. Differentially expressed genes (DEGs) were identified, followed by weighted gene co-expression network analysis (WGCNA), least absolute shrinkage and selection operator (LASSO) and logistic regression to pinpoint independent diagnostic markers. Functional enrichment analyses were performed to explore the biological implications of CD3G expression in depression. Pan-cancer analyses were also conducted to investigate CD3G's role in cancer. Depression patients exhibited significant decreases in CD8 T cells, cytotoxic cells, T cells, T helper cells, Tgd, and Th2 cells, with increased levels of dendritic cells and neutrophils compared to HC. Immune pathway activities showed increased antimicrobial, chemokine, cytokine, and TNF family member activities, with decreased TCR signaling activity in depression patients. CD3G was identified as a key immune-related gene and independent diagnostic marker for depression, validated by GSE76826 dataset. Low CD3G expression in depression was associated with enhanced immune response and inflammatory pathways. In pan-cancer analysis, CD3G was upregulated in numerous cancers and correlated with immune cell infiltration and oncogenic pathways. The study highlights significant dysregulation in immune cell infiltration and pathway activities in depression, with CD3G emerging as a critical immune-related gene and potential diagnostic marker. CD3G's role in immune modulation and cancer underscores its relevance in both depression and oncology, suggesting potential therapeutic targets and prognostic indicators.

抑郁症与免疫系统失调的关系越来越密切。本研究探讨了t细胞受体复合物CD3 γ亚单位(CD3G)作为抑郁症诊断标志物的潜力,同时也研究了其在各种癌症类型中的作用。利用单样本基因集富集分析(ssGSEA)对数据集GSE98793的免疫细胞浸润和通路活性进行对比分析。抑郁症患者是根据临床诊断来定义的,并与没有任何精神疾病的健康对照(HC)进行比较。鉴定差异表达基因(DEGs),然后采用加权基因共表达网络分析(WGCNA)、最小绝对收缩和选择算子(LASSO)和逻辑回归来确定独立的诊断标记。通过功能富集分析探讨CD3G表达在抑郁症中的生物学意义。泛癌症分析也被用于研究CD3G在癌症中的作用。与HC相比,抑郁症患者CD8 T细胞、细胞毒性细胞、T细胞、T辅助细胞、Tgd和Th2细胞显著减少,树突状细胞和中性粒细胞水平升高。抑郁症患者的免疫途径活性显示抗菌、趋化因子、细胞因子和TNF家族成员活性增加,TCR信号活性降低。通过GSE76826数据集验证,CD3G被确定为抑郁症的关键免疫相关基因和独立诊断标志物。抑郁症中CD3G的低表达与免疫反应和炎症途径的增强有关。在泛癌症分析中,CD3G在许多癌症中上调,并与免疫细胞浸润和致癌途径相关。该研究强调了抑郁症中免疫细胞浸润和通路活动的显著失调,CD3G成为一个关键的免疫相关基因和潜在的诊断标志物。CD3G在免疫调节和癌症中的作用强调了其在抑郁症和肿瘤学中的相关性,提示了潜在的治疗靶点和预后指标。
{"title":"Unveiling the dual role of CD3G: a diagnostic biomarker for depression and its oncogenic implications.","authors":"Hai Gao, Ting Wu, Jihui Xue, Jing Liu, Dongmei Wen, Guanwei Huang","doi":"10.3389/ebm.2025.10599","DOIUrl":"10.3389/ebm.2025.10599","url":null,"abstract":"<p><p>Depression has been increasingly associated with immune system dysregulation. This study investigates the potential of CD3 Gamma Subunit of T-Cell Receptor Complex (CD3G) as a diagnostic marker for depression, while also examining its role across various cancer types. Comparative analyses of immune cell infiltration and pathway activities were conducted using single-sample Gene Set Enrichment Analysis (ssGSEA) on datasets GSE98793. Depression patients were defined based on clinical diagnoses and compared to healthy controls (HC) without any psychiatric disorders. Differentially expressed genes (DEGs) were identified, followed by weighted gene co-expression network analysis (WGCNA), least absolute shrinkage and selection operator (LASSO) and logistic regression to pinpoint independent diagnostic markers. Functional enrichment analyses were performed to explore the biological implications of CD3G expression in depression. Pan-cancer analyses were also conducted to investigate CD3G's role in cancer. Depression patients exhibited significant decreases in CD8 T cells, cytotoxic cells, T cells, T helper cells, Tgd, and Th2 cells, with increased levels of dendritic cells and neutrophils compared to HC. Immune pathway activities showed increased antimicrobial, chemokine, cytokine, and TNF family member activities, with decreased TCR signaling activity in depression patients. CD3G was identified as a key immune-related gene and independent diagnostic marker for depression, validated by GSE76826 dataset. Low CD3G expression in depression was associated with enhanced immune response and inflammatory pathways. In pan-cancer analysis, CD3G was upregulated in numerous cancers and correlated with immune cell infiltration and oncogenic pathways. The study highlights significant dysregulation in immune cell infiltration and pathway activities in depression, with CD3G emerging as a critical immune-related gene and potential diagnostic marker. CD3G's role in immune modulation and cancer underscores its relevance in both depression and oncology, suggesting potential therapeutic targets and prognostic indicators.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10599"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-fidelity, personalized cardiac modeling via AI-driven 3D reconstruction and embedded silicone rubber printing. 通过人工智能驱动的3D重建和嵌入式硅橡胶打印进行高保真,个性化的心脏建模。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10756
Xuefang Wang, Yixin Li, Zhiqi Liang, Ruxu Du, Ting Song

The burgeoning clinical demand for patient-specific cardiac modeling encounters significant challenges. The current clinical cardiac models are either difficult to manufacture or lack of detailed geometric structures and hence, often fail to incorporate important patient-specific characteristics. Moreover, most 3D-printable soft materials, such as Thermoplastic Poly-Urethane (TPU) or elastic resins, exhibit insufficient flexibility and biocompatibility to accurately mimic cardiac tissues, therefore limiting their ability to truly replicate patient-specific cardiac conditions. To address these limitations, we propose an innovative method for patient-specific cardiac substructure reconstruction based on the integration of Artificial Intelligence (AI) and embedded 3D printing. First, by combining medical imaging data (CT scan) with AI-driven high-precision 3D reconstruction algorithms, the new method segments the patient-specific cardiac structure into 10 substructures. The average Dice coefficient across the ten substructures is 0.87. Second, it uses an embedded 3D printing technique which utilizes silicone rubber matrix as supporting structure and uses diluted catalyst ink to extrude onto the supporting matrix. Through precise regulation of the matrix composition, material deposition rate and curing time, it can fabricate high-fidelity, complex 3D patient-specific silicone heart models with the average dimensional error less than 0.5 mm. The proposed method can substantially reduce manual intervention and post-processing time. The fabricated models provide valuable morphological insights for cardiovascular diagnosis and treatment planning. It is believed that many clinic applications will follow.

对患者特异性心脏建模的快速增长的临床需求遇到了重大挑战。目前的临床心脏模型要么难以制造,要么缺乏详细的几何结构,因此往往不能纳入重要的患者特异性特征。此外,大多数可3d打印的软材料,如热塑性聚氨酯(TPU)或弹性树脂,都没有足够的灵活性和生物相容性来准确模拟心脏组织,因此限制了它们真正复制患者特定心脏病的能力。为了解决这些限制,我们提出了一种基于人工智能(AI)和嵌入式3D打印集成的患者特异性心脏亚结构重建的创新方法。首先,通过将医学成像数据(CT扫描)与人工智能驱动的高精度3D重建算法相结合,新方法将患者特定的心脏结构划分为10个亚结构。10个子结构的平均Dice系数为0.87。其次,采用嵌入式3D打印技术,利用硅橡胶基质作为支撑结构,并使用稀释的催化剂油墨挤压到支撑基质上。通过对基体成分、材料沉积速率和固化时间的精确调控,可以制作出高保真度、复杂的患者特异性3D硅胶心脏模型,平均尺寸误差小于0.5 mm。该方法可以大大减少人工干预和后处理时间。构建的模型为心血管疾病的诊断和治疗计划提供了有价值的形态学见解。相信许多临床应用也会随之而来。
{"title":"High-fidelity, personalized cardiac modeling via AI-driven 3D reconstruction and embedded silicone rubber printing.","authors":"Xuefang Wang, Yixin Li, Zhiqi Liang, Ruxu Du, Ting Song","doi":"10.3389/ebm.2025.10756","DOIUrl":"10.3389/ebm.2025.10756","url":null,"abstract":"<p><p>The burgeoning clinical demand for patient-specific cardiac modeling encounters significant challenges. The current clinical cardiac models are either difficult to manufacture or lack of detailed geometric structures and hence, often fail to incorporate important patient-specific characteristics. Moreover, most 3D-printable soft materials, such as Thermoplastic Poly-Urethane (TPU) or elastic resins, exhibit insufficient flexibility and biocompatibility to accurately mimic cardiac tissues, therefore limiting their ability to truly replicate patient-specific cardiac conditions. To address these limitations, we propose an innovative method for patient-specific cardiac substructure reconstruction based on the integration of Artificial Intelligence (AI) and embedded 3D printing. First, by combining medical imaging data (CT scan) with AI-driven high-precision 3D reconstruction algorithms, the new method segments the patient-specific cardiac structure into 10 substructures. The average Dice coefficient across the ten substructures is 0.87. Second, it uses an embedded 3D printing technique which utilizes silicone rubber matrix as supporting structure and uses diluted catalyst ink to extrude onto the supporting matrix. Through precise regulation of the matrix composition, material deposition rate and curing time, it can fabricate high-fidelity, complex 3D patient-specific silicone heart models with the average dimensional error less than 0.5 mm. The proposed method can substantially reduce manual intervention and post-processing time. The fabricated models provide valuable morphological insights for cardiovascular diagnosis and treatment planning. It is believed that many clinic applications will follow.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10756"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury. 间充质间质细胞分泌组对肝纤维化合并急性肺损伤的治疗作用。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-30 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10782
Ane Caroline Ribeiro Novaes Martins, Karina Ribeiro Silva, Anna Carolina de Souza Pereira, Gustavo Claudino Paris, Ana Lúcia Rosa Nascimento, Verônica Aiceles, Erika Afonso Costa Cortez, Alessandra Alves Thole, Simone Nunes de Carvalho

Chronic liver disease (CLD) is a widespread condition and liver fibrosis is a common hallmark. The COVID-19 pandemic has drawn awareness over emerging pathogens that pose severe risks for chronic disease patients, whose management is complicated because most drugs can overload liver metabolism, therefore therapeutic alternatives are needed. Aims: based on the difficulty of treating CLD patients during respiratory infections, this study focused on the therapeutic evaluation of adipose-derived mesenchymal stromal cell (ASC) secretome. Methods: the effects of ASC secretome were evaluated in a preclinical murine model of liver fibrosis induced by thioacetamide (TAA) and acute lung injury induced by lipopolysaccharide, using histological and cytokine profile analyses. ASC secretome exhibited therapeutic effects alleviating fibrogenesis and inflammation, decreasing plasmatic inflammatory markers (cytokines IL-6, IL-17A and TNF-α), and restoring immune homeostasis. The secretome reduced liver collagen accumulation and IL-6 levels and restored lung cytoarchitecture, decreasing levels of CD68 and TNF-α. These results provide a preclinical basis for potential clinical use of the ASC secretome and its products, advancing the concept of cell-free, systemically active interventions for complex tissue injuries, and reinforcing the potential of its paracrine factors to modify pathological responses and promote tissue regeneration in combined chronic-acute diseases.

慢性肝病(CLD)是一种广泛的疾病,肝纤维化是一种常见的标志。新冠肺炎疫情让人们意识到,新出现的病原体对慢性疾病患者构成严重威胁,因为大多数药物会使肝脏代谢超负荷,治疗非常复杂,因此需要治疗替代方案。目的:基于CLD患者在呼吸道感染期间的治疗难度,本研究重点对脂肪源性间充质基质细胞(ASC)分泌组的治疗效果进行评价。方法:采用组织学和细胞因子谱分析方法,评价ASC分泌组对巯基乙酰胺(TAA)致肝纤维化和脂多糖致急性肺损伤的临床前小鼠模型的影响。ASC分泌组具有缓解纤维生成和炎症、降低血浆炎症标志物(细胞因子IL-6、IL-17A和TNF-α)和恢复免疫稳态的治疗作用。分泌组降低肝脏胶原积累和IL-6水平,恢复肺细胞结构,降低CD68和TNF-α水平。这些结果为ASC分泌组及其产品的潜在临床应用提供了临床前基础,推进了无细胞、系统活性干预复杂组织损伤的概念,并增强了其旁分泌因子在慢性-急性联合疾病中改变病理反应和促进组织再生的潜力。
{"title":"Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury.","authors":"Ane Caroline Ribeiro Novaes Martins, Karina Ribeiro Silva, Anna Carolina de Souza Pereira, Gustavo Claudino Paris, Ana Lúcia Rosa Nascimento, Verônica Aiceles, Erika Afonso Costa Cortez, Alessandra Alves Thole, Simone Nunes de Carvalho","doi":"10.3389/ebm.2025.10782","DOIUrl":"10.3389/ebm.2025.10782","url":null,"abstract":"<p><p>Chronic liver disease (CLD) is a widespread condition and liver fibrosis is a common hallmark. The COVID-19 pandemic has drawn awareness over emerging pathogens that pose severe risks for chronic disease patients, whose management is complicated because most drugs can overload liver metabolism, therefore therapeutic alternatives are needed. Aims: based on the difficulty of treating CLD patients during respiratory infections, this study focused on the therapeutic evaluation of adipose-derived mesenchymal stromal cell (ASC) secretome. Methods: the effects of ASC secretome were evaluated in a preclinical murine model of liver fibrosis induced by thioacetamide (TAA) and acute lung injury induced by lipopolysaccharide, using histological and cytokine profile analyses. ASC secretome exhibited therapeutic effects alleviating fibrogenesis and inflammation, decreasing plasmatic inflammatory markers (cytokines IL-6, IL-17A and TNF-α), and restoring immune homeostasis. The secretome reduced liver collagen accumulation and IL-6 levels and restored lung cytoarchitecture, decreasing levels of CD68 and TNF-α. These results provide a preclinical basis for potential clinical use of the ASC secretome and its products, advancing the concept of cell-free, systemically active interventions for complex tissue injuries, and reinforcing the potential of its paracrine factors to modify pathological responses and promote tissue regeneration in combined chronic-acute diseases.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10782"},"PeriodicalIF":2.7,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12518174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145299323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-omics analysis identifies the unique high-FDCSP basal cells in triple-negative breast cancer. 多组学分析确定了三阴性乳腺癌中独特的高fdcsp基底细胞。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-25 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10632
Xinya Lu, Zhen Chen, Ying Shao

Follicular dendritic cell secreted protein (FDCSP) is highly expressed in various cancers and has been implicated in tumor migration and invasion, yet its role in triple-negative breast cancer (TNBC) remains poorly understood. Our findings revealed that FDCSP expression was significantly elevated in TNBC compared to normal breast tissue, whereas its expression was significantly reduced in non-TNBC. In TNBC, high FDCSP expression was associated with an increased mutation rate of TP53 and influenced the infiltration of B cells and macrophages. Single-cell transcriptome analysis demonstrated that FDCSP was predominantly highly expressed in basal cells but exhibited low expression in luminal epithelial cells. This observation was further corroborated by spatial transcriptome (ST) analysis. Immunohistochemistry (IHC) assay also confirmed the distinct expression patterns of FDCSP. Cell-cell interaction and receptor-ligand pair analyses indicated that macrophages could interact with the receptor epidermal growth factor receptor (EGFR) in FDCSP highly expressed basal cells by secreting transforming growth factor-β1 (TGF-β1). Then, the co-localization of FDCSP and EGFR in TNBC basal cells was verified by IHC and immunofluorescence (IF) assay. Additionally, we discovered that FDCSP possesses strong predictive capabilities for distinguishing between responders and non-responders to Immune checkpoint blockade (ICB) treatment. Finally, leveraging the CARE database, we identified 14 potential FDCSP-related target drugs. These findings highlight the unique expression pattern of FDCSP in breast cancer, revealing FDCSP as a promising target for therapeutic strategies in TNBC.

滤泡树突状细胞分泌蛋白(FDCSP)在多种癌症中高表达,并与肿瘤迁移和侵袭有关,但其在三阴性乳腺癌(TNBC)中的作用尚不清楚。我们的研究结果显示,与正常乳腺组织相比,FDCSP在TNBC中的表达显著升高,而在非TNBC中的表达显著降低。在TNBC中,FDCSP高表达与TP53突变率升高相关,并影响B细胞和巨噬细胞的浸润。单细胞转录组分析表明,FDCSP主要在基底细胞中高表达,而在管腔上皮细胞中低表达。空间转录组分析进一步证实了这一观察结果。免疫组化(IHC)也证实了FDCSP的不同表达模式。细胞-细胞相互作用和受体-配体对分析表明,巨噬细胞可通过分泌转化生长因子-β1 (TGF-β1)与FDCSP高表达基底细胞中的受体表皮生长因子受体(EGFR)相互作用。通过免疫组化(IHC)和免疫荧光(IF)实验验证了FDCSP和EGFR在TNBC基底细胞中的共定位。此外,我们发现FDCSP在区分免疫检查点阻断(ICB)治疗的应答者和无应答者方面具有很强的预测能力。最后,利用CARE数据库,我们确定了14种潜在的fdcsp相关靶标药物。这些发现突出了FDCSP在乳腺癌中的独特表达模式,揭示了FDCSP作为TNBC治疗策略的一个有希望的靶点。
{"title":"Multi-omics analysis identifies the unique high-FDCSP basal cells in triple-negative breast cancer.","authors":"Xinya Lu, Zhen Chen, Ying Shao","doi":"10.3389/ebm.2025.10632","DOIUrl":"10.3389/ebm.2025.10632","url":null,"abstract":"<p><p>Follicular dendritic cell secreted protein (FDCSP) is highly expressed in various cancers and has been implicated in tumor migration and invasion, yet its role in triple-negative breast cancer (TNBC) remains poorly understood. Our findings revealed that FDCSP expression was significantly elevated in TNBC compared to normal breast tissue, whereas its expression was significantly reduced in non-TNBC. In TNBC, high FDCSP expression was associated with an increased mutation rate of TP53 and influenced the infiltration of B cells and macrophages. Single-cell transcriptome analysis demonstrated that FDCSP was predominantly highly expressed in basal cells but exhibited low expression in luminal epithelial cells. This observation was further corroborated by spatial transcriptome (ST) analysis. Immunohistochemistry (IHC) assay also confirmed the distinct expression patterns of FDCSP. Cell-cell interaction and receptor-ligand pair analyses indicated that macrophages could interact with the receptor epidermal growth factor receptor (EGFR) in FDCSP highly expressed basal cells by secreting transforming growth factor-β1 (TGF-β1). Then, the co-localization of FDCSP and EGFR in TNBC basal cells was verified by IHC and immunofluorescence (IF) assay. Additionally, we discovered that FDCSP possesses strong predictive capabilities for distinguishing between responders and non-responders to Immune checkpoint blockade (ICB) treatment. Finally, leveraging the CARE database, we identified 14 potential FDCSP-related target drugs. These findings highlight the unique expression pattern of FDCSP in breast cancer, revealing FDCSP as a promising target for therapeutic strategies in TNBC.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10632"},"PeriodicalIF":2.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12507714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145279338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet-rich plasma in peripheral nerve injury repair: a comprehensive review of mechanisms, clinical applications, and therapeutic potential. 富血小板血浆在周围神经损伤修复中的作用:机制、临床应用和治疗潜力的综合综述。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-23 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10746
Kai Shang, Yang Liu, Abdul Qadeer

Peripheral nerve injuries (PNIs) pose a significant clinical challenge, often leading to incomplete functional recovery despite current treatments. Platelet-rich plasma (PRP), which contains high levels of growth factors and bioactive molecules, has emerged as a promising regenerative therapy for nerve repair and restoring function. This review consolidates current evidence on PRP applications in treating peripheral nerve injuries, examining molecular mechanisms, clinical outcomes, and therapeutic potential. PRP markedly enhances nerve regeneration, improves recovery of sensory and motor functions, and alleviates neuropathic pain across various nerve injuries. It promotes axonal growth, reduces scar formation, stimulates Schwann cell proliferation, and modulates inflammation through the release of neurotrophic factors, including PDGF, VEGF, TGF-β, and IGF-1. Combining PRP with surgical techniques and biomaterial scaffolds yields better therapeutic results. Key factors influencing efficacy include platelet concentration, leukocyte content, activation methods, and patient-specific variables. PRP is a safe and effective option for peripheral nerve injury repair. However, challenges persist in standardizing preparation protocols, optimizing treatment timing, and fully understanding molecular mechanisms. Future research should focus on personalized PRP formulations, combination therapies, and large-scale randomized controlled trials to develop definitive clinical guidelines.

周围神经损伤(PNIs)是一个重大的临床挑战,尽管目前的治疗往往导致功能恢复不完全。富血小板血浆(PRP)含有高水平的生长因子和生物活性分子,已成为一种有前途的神经修复和恢复功能的再生疗法。本文综述了目前关于PRP在治疗周围神经损伤中的应用、分子机制、临床结果和治疗潜力的证据。PRP可显著促进神经再生,改善感觉和运动功能的恢复,减轻各种神经损伤的神经性疼痛。它促进轴突生长,减少疤痕形成,刺激雪旺细胞增殖,并通过释放神经营养因子,包括PDGF、VEGF、TGF-β和IGF-1来调节炎症。PRP与外科技术和生物材料支架相结合,治疗效果更好。影响疗效的关键因素包括血小板浓度、白细胞含量、活化方法和患者特异性变量。PRP是一种安全有效的修复周围神经损伤的方法。然而,在标准化制备方案、优化治疗时机和充分了解分子机制方面仍然存在挑战。未来的研究应侧重于个性化PRP配方、联合治疗和大规模随机对照试验,以制定明确的临床指南。
{"title":"Platelet-rich plasma in peripheral nerve injury repair: a comprehensive review of mechanisms, clinical applications, and therapeutic potential.","authors":"Kai Shang, Yang Liu, Abdul Qadeer","doi":"10.3389/ebm.2025.10746","DOIUrl":"10.3389/ebm.2025.10746","url":null,"abstract":"<p><p>Peripheral nerve injuries (PNIs) pose a significant clinical challenge, often leading to incomplete functional recovery despite current treatments. Platelet-rich plasma (PRP), which contains high levels of growth factors and bioactive molecules, has emerged as a promising regenerative therapy for nerve repair and restoring function. This review consolidates current evidence on PRP applications in treating peripheral nerve injuries, examining molecular mechanisms, clinical outcomes, and therapeutic potential. PRP markedly enhances nerve regeneration, improves recovery of sensory and motor functions, and alleviates neuropathic pain across various nerve injuries. It promotes axonal growth, reduces scar formation, stimulates Schwann cell proliferation, and modulates inflammation through the release of neurotrophic factors, including PDGF, VEGF, TGF-β, and IGF-1. Combining PRP with surgical techniques and biomaterial scaffolds yields better therapeutic results. Key factors influencing efficacy include platelet concentration, leukocyte content, activation methods, and patient-specific variables. PRP is a safe and effective option for peripheral nerve injury repair. However, challenges persist in standardizing preparation protocols, optimizing treatment timing, and fully understanding molecular mechanisms. Future research should focus on personalized PRP formulations, combination therapies, and large-scale randomized controlled trials to develop definitive clinical guidelines.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10746"},"PeriodicalIF":2.7,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variational autoencoder enhanced analysis of energy metabolism and autophagy in exercising cardiomyocytes. 变分自编码器增强了运动心肌细胞能量代谢和自噬的分析。
IF 2.7 4区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-22 eCollection Date: 2025-01-01 DOI: 10.3389/ebm.2025.10489
Liquan Chen, Yun Yang

Autophagy of myocardial cells involves the interaction of multiple molecular signaling pathways, and regulatory factors, while existing methods are difficult to handle. This study utilized the variational autoencoder (VAE) model to reveal the characteristic distribution of myocardial cell energy autophagy under different exercise conditions. First, this paper is based on mass spectrometry analysis, enzyme-linked immunosorbent assay ELISA (Enzyme-Linked Immunosorbent Assay) to determine the cardiomyocyte metabolite concentration data, and RNA-Seq (Ribonucleic Acid-Sequencing) to collect genes related to cardiomyocyte energy metabolism and autophagy expression data; in the VAE model, this paper utilizes the full connectivity layer to encode the data into potential representations, and reconstructs the numerical data through the numerical data decoder. The loss function is defined as the data reconstruction error and KL (Kullback-Leibler) scatter, and Adam is used to optimize the training process; the features are analyzed and the classification performance is verified under different motion conditions based on RF (Random Forest); the relationship between the features and metabolite concentration and gene expression is analyzed by LASSO (Least Absolute Shrinkage and Selection Operator) regression model to analyze the relationship between features and metabolite concentration and gene expression; the features in the latent space are downscaled using t-SNE (t-distributed Stochastic Neighbor Embedding) to visualize the feature distribution; finally, CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-Cas9) knockdown experiments to reveal the importance of AMPK, PGC1A, CPT1B, and SIRT1 in cardiomyocyte autophagy and energy metabolism, which provide potential targets for future gene-based therapies.

心肌细胞自噬涉及多种分子信号通路和调控因子的相互作用,现有方法难以处理。本研究利用变分自编码器(VAE)模型揭示不同运动条件下心肌细胞能量自噬的特征分布。首先,本文基于质谱分析、酶联免疫吸附试验ELISA (enzyme-linked immunosorbent assay)测定心肌细胞代谢物浓度数据,以及RNA-Seq (Ribonucleic Acid-Sequencing)采集心肌细胞能量代谢相关基因和自噬表达数据;在VAE模型中,本文利用全连接层将数据编码为潜在表示,并通过数字数据解码器重构数字数据。将损失函数定义为数据重构误差和KL (Kullback-Leibler)散点,利用Adam算法对训练过程进行优化;分析了基于随机森林的特征,验证了在不同运动条件下的分类性能;采用LASSO (Least Absolute Shrinkage and Selection Operator)回归模型分析特征与代谢物浓度与基因表达的关系,分析特征与代谢物浓度与基因表达的关系;利用t-SNE (t-分布随机邻居嵌入)对潜在空间中的特征进行降尺度处理,使特征分布可视化;最后,通过CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-Cas9)敲低实验,揭示AMPK、PGC1A、CPT1B和SIRT1在心肌细胞自噬和能量代谢中的重要性,为未来的基因治疗提供潜在靶点。
{"title":"Variational autoencoder enhanced analysis of energy metabolism and autophagy in exercising cardiomyocytes.","authors":"Liquan Chen, Yun Yang","doi":"10.3389/ebm.2025.10489","DOIUrl":"10.3389/ebm.2025.10489","url":null,"abstract":"<p><p>Autophagy of myocardial cells involves the interaction of multiple molecular signaling pathways, and regulatory factors, while existing methods are difficult to handle. This study utilized the variational autoencoder (VAE) model to reveal the characteristic distribution of myocardial cell energy autophagy under different exercise conditions. First, this paper is based on mass spectrometry analysis, enzyme-linked immunosorbent assay ELISA (Enzyme-Linked Immunosorbent Assay) to determine the cardiomyocyte metabolite concentration data, and RNA-Seq (Ribonucleic Acid-Sequencing) to collect genes related to cardiomyocyte energy metabolism and autophagy expression data; in the VAE model, this paper utilizes the full connectivity layer to encode the data into potential representations, and reconstructs the numerical data through the numerical data decoder. The loss function is defined as the data reconstruction error and KL (Kullback-Leibler) scatter, and Adam is used to optimize the training process; the features are analyzed and the classification performance is verified under different motion conditions based on RF (Random Forest); the relationship between the features and metabolite concentration and gene expression is analyzed by LASSO (Least Absolute Shrinkage and Selection Operator) regression model to analyze the relationship between features and metabolite concentration and gene expression; the features in the latent space are downscaled using t-SNE (t-distributed Stochastic Neighbor Embedding) to visualize the feature distribution; finally, CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-Cas9) knockdown experiments to reveal the importance of AMPK, PGC1A, CPT1B, and SIRT1 in cardiomyocyte autophagy and energy metabolism, which provide potential targets for future gene-based therapies.</p>","PeriodicalId":12163,"journal":{"name":"Experimental Biology and Medicine","volume":"250 ","pages":"10489"},"PeriodicalIF":2.7,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12498553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145244118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental Biology and Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1